DatasetName,NUCB1_S(364),NUCB1_S(223) NUCB1_S(224) NUCB1_S(320) NUCB1_S(367) NUCB1_S(369) NUCB1_S(5) NUCB1_S(86) NUCB1_T(148) NUCB1_T(443)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,0.48891677002480616
FSO2013_Ratio M/L normalized Rep3,,0.5009209076868266
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,0.49875029540464155
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,0.5120540236004402
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,0.47021737424027876
AH2018_LFQ_IT_1_C,,
RKK2015_TNF-α/basal,,0.476874891834742
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,0.4770130678105443
NJH2025_Sub7_MICT_Post,,0.4827210076753915
DL2023_control-3,,
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,,0.4766026426414828
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.47931610628212684
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.49595072487261516
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,0.4652113114839173
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,0.4811822177622992
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,0.46236598880787155
FSO2013_Ratio M/L normalized Rep1___1,,0.47960423190759144
SAS2015_AZD/DMSO_Exp3,,0.4874286661720509
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,0.4834008177782994
WZ2023_Pu_010_30min,,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,0.4801003299445047
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,
RB2022_8_RecoveryEndurance,,0.4843458490510074
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,0.49771400454907055
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,0.48279236107165563
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,0.485742607647616
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,0.48433122038613025
LY2019_P1+,,0.4981690172297262
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,0.4928008289919405
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.4767864728810232
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,0.48768901486997573
GF2025_P6_Sph,,0.5195639150053692
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,0.4856120189566162
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,,
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,,0.468457388854516
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,0.4777270956138676
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,,0.4793417419180789
FR2021_Norm.Intensity.B,,0.5208563059750198
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,0.5044199679294026
CR2017_Ratio Replicate 1.3,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,
HS2024_7_PD_T2,,0.48514487968876213
FSO2013_Ratio H/L normalized Rep1___1,,0.46875138771724756
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,0.4721511234460311
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,,
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,
FSO2013_Ratio H/L normalized Rep2,,0.512349594395496
WZ2023_Pu_005_20min,,
NJH2024_Sub10_MICT_Post,,0.47235363579546497
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,,0.4847814726591678
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,0.4991110954614241
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,
NJH2025_Sub7_MICT_Pre,,0.48496291678525555
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,0.46273805256493894
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,0.45958625616524995
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,0.4849625197194
FR2021_Norm.Intensity.H,,0.5166147437942801
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,0.5255267600767202
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,,
PG2020_Intensity Mock_10h_D,,0.468759755075491
SR2019_MCF10A_Biol_repl_2,,0.4951663505813582
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,0.49417841866753354
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.4731100884360504
RCJD2014_5min_1,,0.5013935198774016
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,0.5000884197937918
CR2017_Ratio Replicate 3.3,,
PG2020_Intensity 2h_C,,0.4824011593920814
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,0.47235363579546497
HS2024_6_I_T3,,0.4915435431124792
RN2012_L11,,0.5047789696743517
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,0.48704680000941525
AH2018_LFQ_M_2_C,,
CK2022_3 40-1,,
RBK2021_1260T Early,,0.48578825940933484
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,0.49299690281709313
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,0.7100434824562337,0.5159648586803605
ZQ2022_N2,,0.47788746455108444
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,
EJN2021_5_Rest_Basal,,0.49724892718822766
NJH2025_Sub2_HIIT_Post,,0.4607535351987245
NJH2025_Sub1_MICT_Post,,0.4935498379822665
HS2024_9_B_T1,,0.4667585161104507
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,,0.4759937729322819
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,0.48924166203351327
CR2017_Ratio Replicate 3,,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,0.47588702157474444
RB2022_3_PostSprint,,0.5035018762054762
NJH2024_Sub13_MICT_Mid,,0.4740322569799454
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.521090815214716
HS2024_8_I_T3,,0.4734412202220237
CF2017_EOC 3,,0.5132608750322283
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,0.4757605475669082
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,0.48677277947103614
WZ2023_Pu_010_20min,,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,0.47021737424027876
AH2018_LFQ_IT_1_N,,
FSO2013_Ratio H/M normalized Rep2,,0.5024126319649355
RAM2015_Log2 A,,
HS2024_8_PD_T1,,0.4808772118637509
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,0.49810151228750615
KS2014_Intensity E15_2,,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,0.4884562200717566
HS2024_7_I_T1,,0.5158062500363633
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,0.4830897594050118
SR2019_JIMT1_Biol_repl_1,,0.4722407173436232
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,0.5002996847143911
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,,0.4840074461855121
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,0.4993468093645539
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,0.48349035500703447
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,0.48326525534242293
HS2024_6_B_N1,,0.46529965676485446
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,0.4811822177622992
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.48449446278416786
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.49457788349532916
FSO2013_Ratio M/L normalized Rep2,,0.49882059241582916
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.7112117531776434,0.4964418331168676
SR2019_HCC1954_Biol_repl_2,,0.49335615871698263
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,0.47729381968520457
PG2020_Intensity 4h_D,,0.47511259928097016
NJH2025_Sub2_MICT_Post,,0.47912846331990255
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,,0.45787092753465786
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,
EJN2021_4_Rest_Ins,,0.4985902442761517
RN2012_H05,,0.5061899935490711
NJH2024_Sub7_HIIT_Mid,,0.4826524704702324
GF2025_P2_Adh,,0.4606345971761587
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,0.5011780044490207
HH2022_Reporter intensity 3,0.6022196337041322,0.48803019758427485
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,
JW2021_After_3,,
GF2025_P8_Sph,,0.4853207848021447
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,
CK2022_11 200-1,,
CK2022_12 200-1,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,0.4943307923226868
HH2022_Reporter intensity 9,0.6666529644702729,0.4814001696844913
WZ2023_Su_010_20min,,
AH2018_TMTMS2_2_N,,
NJH2024_Sub13_MICT_Pre,,0.47613719308982666
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,,
KS2014_Intensity N4,,
NJH2024_Sub1_HIIT_Post,,0.4934051797026871
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,0.47301191306725177
CF2017_OSE 26,,0.49977683857960453
CK2022_14 200-1,,
SR2019_Hs578T_Biol_repl_1,,0.4863078729222916
RB2022_7_PostSprint,,0.495160507802047
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,0.4760286030712854
AH2018_TMTMS3_1_N,,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,,0.48154220071325926
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,0.47912846331990255
EJN2021_2_Rest_Ins,,0.5012149921094866
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,,0.46142366207413155
GF2025_P1_Sph,,0.5066249612028264
EJN2021_5_Ex_Basal,,0.49809885895993333
HS2024_7_I_T3,,0.477750883310341
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,,
CF2017_EOC 1,,0.5127386515911367
CK2022_3 200-1,,
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,0.473759683044519
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,0.47672352972049953
NJH2024_Sub13_MICT_Post,,0.47301191306725177
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,0.4939881979954529
RCJD2014_20min_2,,0.4725155222284532
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,0.50201925714489
HS2024_5_B_T1,,0.4527115763964981
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,0.4743554887841584
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,0.48086884049594175
CK2022_4 200-1,,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,,0.48958919969274983
HS2024_4_B_T1,,0.4837611635144725
MV2014_Ratio M/H normalized A3___1 (10 min),,0.48610691086097735
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,0.4993509128414639
NJH2025_Sub8_MICT_Post,,0.49007190341967355
RCJD2014_5min_3,,0.4810891511534952
CR2017_Ratio Replicate 3.2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.4791413158471662
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,0.4829559734525902
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,0.4873527215439986
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,,0.49524111915560887
AH2018_TMTMS3_3_X,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,0.4922091424185212
AH2018_SILAC_M_1_N,,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,0.47301191306725177
PG2020_Intensity CT_D,,
NJH2025_Sub9_MICT_Post,,0.48495012717537556
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,0.4773908637101401
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,0.4935498379822665
HS2024_3_I_T2,,0.4532212385287396
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,0.5159400879897474
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.503443118363215
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,0.4760286030712854
NJH2024_Sub8_MICT_Pre,,0.4909925735505043
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.5131302699826252
HH2022_Reporter intensity 6,0.7136503578356103,0.46180583705064954
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.47395847356523635
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,
GF2025_P3_Adh,,0.46981215777216634
SR2019_JIMT1_Biol_repl_2,,0.4859698282285069
AH2018_TMTMS2_1_C,,
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.48598939697845317
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,0.4957960231635018
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,0.4810435360735895
NJH2025_Sub1_MICT_Mid,,0.4947840225695834
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,0.4865685411692713
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.4984492756319228
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,0.4928414974780427
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,0.4953415689094382
RB2022_7_RecoverySprint,,0.4981654225875905
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,,0.48706815467533005
AH2018_LFQ_1_X,,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,0.4818801478093105
FR2021_Norm.Intensity.M,,0.5129632431075509
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,
HH2022_Reporter intensity 1,0.5910372899254526,0.4882097100536582
HH2022_Reporter intensity 2,0.6002663546695134,0.4885756400178336
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,0.5081833788213832
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,0.5002276837558671
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,0.46780264934813665
CR2017_Ratio Replicate 2,,0.5102893998776732
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.5206512345125414
AR2021_KD 72h,,0.47270542527418846
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,0.49007190341967355
AH2018_TMTMS3_3_C,,
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,0.4730152448079419
CF2017_OSE 29,,0.4939670564062139
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,0.4934051797026871
DL2023_24h-2,,
HS2024_7_B_N2,,0.5066956141892623
PG2020_Intensity 10h_A,,0.49563862129315034
RN2012_L12,,0.4750495555807937
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,0.4899740090711646
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,,0.4811362818666136
FR2021_Norm.Intensity.A,,0.5166208196844619
FSO2013_Ratio H/M normalized Rep1___1,,0.4718998092761246
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,0.47587817138867483
NJH2025_Sub12_HIIT_Post,,0.473759683044519
EJN2021_4_Ex_Basal,,0.5008316246476744
TM2022_S2.12h.B,,
RN2012_L15,,0.5019448043380598
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.4643211524607673
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,,0.4740322569799454
KS2014_Intensity C3,,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,0.4967216537038495
CK2022_7 200-1,,
CK2022_5 200-1,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.5129214145016319
NJH2024_Sub10_HIIT_Mid,,0.4701196806657848
RB2022_2_PostEndurance,,0.463994574474752
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,,0.4960691134426629
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,0.47689325163477153
FSO2013_Ratio H/M normalized Rep1,,0.4701600906616097
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,0.4841595003278533
EJN2021_2_Ex_Ins,,0.49853693082405975
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,,0.4808883834251283
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,0.48433122038613025
PG2020_Intensity 6h_B,,0.4895392471736046
FSO2013_Ratio H/L normalized Rep3,,0.5179358860531206
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,0.5079488666507435
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,0.4770708153535001
HS2024_6_B_N2,,0.4652234717317443
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,,
AH2018_SILAC_IT_1_X,,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,0.4873598962251155
UK2020_UA_2,,0.4947056534777402
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.5236445889581783
WZ2023_Pe_025_20min,,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,
HS2024_4_I_N2,,0.5350790470211243
AH2018_TMTMS2_3_N,,
RN2012_H06,,0.5048784819761768
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,0.4893088144286517
WZ2023_Su_005_30min,,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,0.4777083450466142
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,0.49420463596042197
NJH2024_Sub10_HIIT_Post,,0.4698106683895291
CR2017_Ratio Replicate 3.1,,
WZ2023_Su_025_10min,,
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,0.4820547434959569
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,,
MV2014_Ratio H/M normalized A2___1 (2 min),,0.4701576076137741
PG2020_Intensity 8h_D,,0.48565427025438535
LY2019_P7+,,0.46815951680974155
EP2017_Untreated R#1 normalized log2 ratio,,0.4935664117454908
RN2012_L10,,0.49084852810587115
PG2020_Intensity 4h_C,,0.4736008394307535
EP2017_Mitotic R#3 normalized log2 ratio,,0.47572571103478456
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,,0.49243028061747335
AH2018_SILAC_IT_2_X,,
HS2024_4_B_T3,,0.4766797828615226
NJH2024_Sub2_HIIT_Post,,0.4607535351987245
HS2024_8_B_N2,,0.4382524548859037
NJH2025_Sub8_HIIT_Pre,,0.4928414974780427
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,0.49865005662546324
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,0.4902283734932278
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.474210903647833
GF2025_P9_Sph,,0.514466468215762
CK2022_6 200-1,,
NJH2024_Sub7_MICT_Post,,0.4827210076753915
AH2018_TMTMS3_2_X,,
NJH2024_Sub8_HIIT_Post,,0.4876406161830402
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,0.4985457479782054
HS2024_4_I_T2,,0.4751139655955245
NJH2024_Sub2_MICT_Mid,,0.4770708153535001
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,0.47839312037592246
SAS2015_AZD/DMSO_Exp1,,0.48726446233650456
NJH2024_Sub1_MICT_Mid,,0.4947840225695834
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,0.47869050360077814
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,0.47613719308982666
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,0.4750642368156927
EP2017_Untreated R#3 normalized log2 ratio,,0.4870638862423321
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,0.4858319254468879
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,,0.48905376545574986
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.4772240323256533
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,0.5055970478837429
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,,0.47608868170777224
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,0.4878305759654757
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,0.49255228869473705
EJN2021_1_Ex_Basal,,0.4997518613386532
FR2021_Intensity.M,,0.5129632431075509
RB2022_2_PostSprint,,0.49022884687257157
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.4950817479337693
PG2020_Intensity CT_C,,0.4789741131674002
ZCP2016_Ratio H/L Rep 1,,0.44723256271197975
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,,0.4869129043868171
RB2022_2_PostStrength,,0.46851444637629125
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,,0.49491222301206456
HS2024_8_PD_T2,,0.4774619277077734
FS2019_Ctr2,,0.4856476240812453
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,0.5092209646797978
NJH2025_Sub9_HIIT_Post,,0.4840074461855121
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,0.4442377387093362
NJH2025_Sub10_MICT_Mid,,0.47672352972049953
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,0.5056075350378032
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.46715941496533975
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,0.47301191306725177
HS2024_4_B_N2,,0.5039350922908343
HS2024_3_PD_T3,,0.48203436570720815
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,0.4714474698877356
FR2021_Intensity.G,,0.5135890399074253
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,,
RAM2015_Log2 B,,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,0.4909925735505043
EJN2021_4_Rest_Basal,,0.4990738404791338
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,0.49114939451708917
UK2020_HCM_5,,0.49381856839132676
NJH2025_Sub10_HIIT_Post,,0.4698106683895291
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,0.4592421647201726
PG2020_Intensity Mock_10h_B,,0.4824663822487355
WZ2023_Su_025_30min,,
AH2018_LFQ_4_N,,
CR2017_Ratio Replicate 1.2,,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,0.4434823667190264
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.7451706055432676,0.47987904436032675
AH2018_SILAC_M_1_X,,
RB2022_7_PreEndurance,,0.4725031410498086
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,0.5081522709550921
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.45715421302738934
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,0.4756844075375979
NJH2025_Sub7_HIIT_Mid,,0.4826524704702324
MV2014_Ratio H/L normalized B1___1 (30 min),,0.48634728910387204
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,0.48008221633749826
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,0.46797743802346303
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,0.4786488931873653
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,0.487751426035964
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,
NJH2024_Sub8_HIIT_Mid,,0.48825944928985443
PG2020_Intensity 8h_B,,0.48800189862069676
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,,0.48070280484205025
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,0.473579037246325
KS2014_Intensity E15_3,,
GF2025_P3_Sph,,0.5000520977922762
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,0.4841216685127865
AH2018_SILAC_1_C,,
NJH2024_Sub1_HIIT_Pre,,0.4993468093645539
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.4913099164353759
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,0.48198333406162913
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,,0.5128488049872444
ZQ2022_N1,,0.4785620980212219
LY2019_P6-,,0.5124969069297576
RM2024_Intensity D2-3,,
UK2020_HCM_1,,0.4930397124862943
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,0.4783208100448918
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.5101571384645136
AH2018_LFQ_3_N,,
RKK2015_TNF-α/IKKb,,0.4794149889452817
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,0.49349243311057844
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,0.48660584401722673
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,0.4701196806657848
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.47978432081148675
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,0.4719529052408252
HS2024_5_PD_T2,,0.5079070563256181
WZ2023_Su_025_20min,,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.5022879798593028
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.46637824697076596
NJH2024_Sub2_HIIT_Pre,,0.48008221633749826
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,0.511073626667595
PG2020_Intensity 10h_D,,0.49544249591710593
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,0.5306308948236674
EJN2021_4_Ex_Ins,,0.5008983785735612
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,0.4993747700109603
EP2017_Pervanadate R#3 log2 ratio,,0.47661376233428915
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,0.473873543543199
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,0.5033440087345755
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,,0.5279168838186509
FR2021_Intensity.A,,0.5120529682600363
EJN2021_3_Ex_Ins,,0.5014866349180369
MV2014_Ratio M/L normalized A1___1 (2 min),,0.48948558105641266
WZ2023_Pe_005_30min,,
HS2024_8_PD_T3,,0.45985087543489467
EJN2021_3_Ex_Basal,,0.5039272972586853
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,0.48194651509815856
FS2019_Ctr3,,0.49028551204207843
WZ2023_Pu_025_20min,,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,0.48830685899885673
RB2022_1_RecoveryStrength,,0.47324407267204704
SR2019_HCC1954_Biol_repl_4,,0.49317918258750015
FR2021_Norm.Intensity.N,,0.5132697943890632
HS2024_5_B_N1,,0.49240860502505257
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,
HS2024_8_I_N2,,0.45154567133453294
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,
LY2019_P8+,,0.5051260011528035
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,0.4925809946520552
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,0.4864419485060313
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.4864033215898037
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,0.4865786061354859
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,0.49347726570410916
LY2019_P2-,,0.4814442543513857
AH2018_LFQ_IT_1_X,,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,0.4972349947419604
WZ2023_Pe_005_20min,,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,0.49106953909527046
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,0.45942233204864547
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,0.49752929682288133
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,0.48495012717537556
CF2017_OSE 28,,0.49360178917910563
HS2024_5_B_T2,,0.4870994175382602
HS2024_6_I_T1,,0.48873894642878984
HS2024_5_B_T3,,0.47122253166380734
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,0.5132657372767114
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,,0.4939881979954529
NJH2025_Sub8_HIIT_Mid,,0.48825944928985443
EP2017_Mitotic R#3 log2 ratio,,0.4780647718562133
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,,
KS2014_Intensity C2,,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,
NJH2024_Sub9_MICT_Mid,,0.4865685411692713
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,0.5495631866438263
RBK2021_1332T Late,,0.5031166923786458
LY2019_P1-,,0.48473070586193895
RKK2015_TNF-α/basal.1,,0.4689759608373599
RKK2015_TNF-α/TNF-α+SC-514,,0.47199687840065807
CR2017_Ratio Replicate 2.5,,0.5119479891889617
HS2024_3_I_T3,,0.49200269708279976
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,
ZQ2022_C3,,0.5053699319724121
EJN2021_3_Rest_Ins,,0.5036539571566188
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,0.4943307923226868
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,0.49344114768090297
RKK2015_SC-514/basal,,0.4666693183308749
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,
NJH2025_Sub9_HIIT_Mid,,0.4856120189566162
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,0.48388304307884933
KS2014_Intensity N1,,
NJH2024_Sub12_MICT_Post,,0.4783208100448918
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,0.46366704670357756
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,0.4786870912598681
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,0.46827286428442455
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,0.4709969731823736
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,0.4989434812120756
HS2024_5_B_N2,,0.49874438910678465
HS2024_5_I_N1,,0.49404872352186946
HS2024_6_I_N1,,0.4984819749125826
AR2021_KD 48h,,0.4885688564889472
FR2021_Intensity.B,,0.520931989776456
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,0.4604876185235761
NJH2024_Sub10_MICT_Pre,,0.475496553487232
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,,
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,,0.5013702536090938
AH2018_LFQ_M_2_X,,
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,0.47557875403784927
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,,
RN2012_H01,,0.5014767126425066
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,0.5016479428774318
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.48230300421899763
HS2024_8_B_T3,,0.5093524762088498
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,0.4885118563509034
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,0.5025243303412457
RCJD2014_10min_mean,,0.47461897278460374
KS2014_Intensity C1,,
FSO2013_Ratio H/M normalized Rep3___1,,0.5203245156486141
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,,0.5066721692814268
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,
AH2018_SILAC_M_2_X,,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,,
PG2020_Intensity 6h_C,,0.48450044017299326
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,,0.4964845444804003
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,0.508514463697336
GF2025_P8_Adh,,0.45725217759386716
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.5107330775063076
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.4798283662739567
NJH2024_Sub2_HIIT_Mid,,0.46903458968383405
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,0.4652113114839173
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,0.47729381968520457
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,0.4951581831941028
SAS2015_AZD/DMSO_Exp2,,0.478467909193695
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,0.4751977368403393
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,0.4765052317797738
EJN2021_2_Ex_Basal,,0.5003925215041289
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,0.5030519850709236
AR2021_L41 10 μM,,0.4617367957027257
CF2017_EOC 2,,0.5161290199127155
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,
NJH2024_Sub10_HIIT_Pre,,0.4714474698877356
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,0.49560182805112923
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,0.4786488931873653
HS2024_3_PD_T2,,0.4945859737703215
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5932697855723515,0.4878104562346177
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,
AR2021_L41 1 μM,,0.4721079049071331
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,
NJH2025_Sub10_MICT_Pre,,0.475496553487232
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,,0.4873527215439986
RCJD2014_20min_1,,0.5046804733363972
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,0.5011473830741369
HS2024_7_B_T2,,0.5063065662610972
SAS2015_PLX/DMSO_Exp3,,0.4789045915464377
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,0.46903458968383405
AH2018_LFQ_M_3_C,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,
WZ2023_Pu_025_10min,,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,0.513890533608492
FSO2013_Ratio M/L normalized Rep3___1,,0.500544625824801
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,0.45042455412721644
CF2017_EOC 4,,0.49824624702359493
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,,
ZQ2022_N3,,0.47790531755366206
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,0.48496291678525555
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,,
CK2022_5 40-1,,
AH2018_LFQ_3_X,,
UK2020_UA_3,,0.4945128078971128
LY2019_P7-,,0.4716012949897178
GF2025_P5_Adh,,0.4745241943452275
RB2022_1_PostStrength,,0.46120944563919747
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5193542684362847
SR2019_HCC1954_Biol_repl_3,,0.49311148171758085
CR2017_Ratio Replicate 2.2,,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,0.4999311116263541
CR2017_Ratio Replicate 2.1,,0.5251958571184782
PG2020_Intensity CT_B,,0.47524398491346187
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,0.4784370969677069
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,0.4865786061354859
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,0.4892939532363345
AH2018_LFQ_3_C,,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,0.4876406161830402
AH2018_LFQ_M_3_X,,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.4799171080122592
RB2022_2_PreEndurance,,0.4754279012351601
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,0.5166147437942801
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,0.4871904616188563
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,0.4974969760228014
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,0.4965080777857805
EP2017_Mitotic R#2 log2 ratio,,0.475150845419639
AH2018_TMTMS2_1_X,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,0.5310203188490756
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,0.4926065662743546
NJH2025_Sub8_MICT_Mid,,0.4899740090711646
EJN2021_5_Ex_Ins,,0.49555678630695954
HS2024_6_I_N2,,0.4950153906098929
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,0.5292231452029109
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,0.4770130678105443
RCJD2014_15min_3,,0.4909006797292927
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.48684550691371087
HS2024_4_I_T3,,0.45847729242619906
AH2018_SILAC_1_X,,
PG2020_Intensity 10h_B,,0.4974016740101127
AH2018_TMTMS3_1_X,,
CF2017_FTE 14,,0.5047376148528578
NJH2024_Sub13_HIIT_Post,,0.46827286428442455
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,0.4858319254468879
RBK2021_1259T Early,,0.48405902483007207
RKK2015_IKK+TNF-α/IKKb,,0.49329748249652994
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,0.4845519361900247
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,,0.5003774459279984
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.4832590990459465
HS2024_5_I_N2,,0.48190484991501825
SAS2015_PLX/AZD_Exp3,,0.476137884421999
EP2017_Pervanadate R#2 log2 ratio,,0.4770307492878573
AS2011_Ratio H/L Normalized RNAi_2_1,,
